|
|
||||||||
Scientific Section |
Department of Orthodontics and Dental Research Centre, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran
School of Dentistry, Kerman University of Medical Sciences, Kerman, Iran
Department of Pharmacology, School of Medicine, Azad University of Medical Sciences, Tehran, Iran
Department of Oral Pathology, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran
School of Medicine, UCLA University of Medical Sciences, Los Angeles, CA, USA
Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences/University of Tehran, Tehran, Iran
Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Address for correspondence: Professor Ahmed R. Dehpour, Department of Pharmacology, School of Medicine, Medical Sciences/University of Tehran, Tehran, Iran. Email: dehpour{at}yahoo.com
Received 13 January 2007; accepted 4 February 2008
| Abstract |
|---|
|
|
|---|
Design: Basic science, animal experimental study.
Setting: This study was conducted in the Department of Pharmacology, School of Medicine at Tehran University of Medical Sciences in 2007.
Participants: A total of 40 male Sprague–Dawley rats (150–200 g) were divided into five experimental groups: non-operated, cholestatic-sham, cirrhotic-sham, cholestatic and cirrhotic groups.
Methods: An orthodontic appliance, consisting of a 5 mm nickel titanium closed coil spring, was ligated between the maxillary right incisor and first molar of each rat to deliver an initial force of 60 g. The cholestatic and cirrhotic groups underwent a bile duct ligation operation and received an orthodontic appliance for 7 days (cholestatic group) and 28 days (cirrhotic group) after surgery. Two other groups underwent a sham operation and had an orthodontic appliance inserted after 7 (cholestatic-sham) and 28 days (cirrhotic-sham). A fifth control group underwent neither bile duct ligation operation nor sham operation.
Results: The cirrhotic group showed significantly increased orthodontic tooth movement (OTM), compared to all other study groups (P<0.001). The mean OTM in the cholestatic group was significantly higher than in the other three groups (two sham groups and unoperated one) (P<0.01). Bone density was also significantly decreased in the bile duct ligated (cirrhotic and cholestatic) groups (P<0.01).
Conclusion: Our data demonstrated that biliary cirrhosis could cause a significant increase in the OTM and decrease in the bone density in rats, though there was no significant alteration in bone resorption or osteoclasts detected in such animals.
Key words: Orthodontic tooth movement, densitometry, resorption, cholestasis, cirrhosis
| Introduction |
|---|
|
|
|---|
Cholestasis is impaired bile secretion and results in several systemic complications such as metabolic bone disorders.1
Bone loss and reduced osteoblastic function have been reported in patients with cholestatic liver disease.2
Reduced bone mass is a common finding in patients with cirrhosis, especially in those with cholestatic liver disease. Moreover, earlier studies conducted in humans revealed various patterns of bone abnormalities in cirrhotic patients, including osteomalacia (normal bone quantity, but poorly mineralized)3
–5
as well as various forms of osteoporosis (reduced bone quantity and quality) such as decreased bone formation (which is also called low bone turnover osteoporosis),1
,2
,6
,7
increased formation/resorption rates (high bone turnover osteoporosis).8
,9
Despite the well-known effects of cholestasis and cirrhosis on skeletal tissue, little is known about their effect on orthodontic treatment. On the other hand, it is noteworthy that cirrhotic liver disease, especially alcohol-induced, and its complications is still one of the most frequent causes of mortality and morbidity in the Western world, though its pathophysiology has not been completely elucidated.10
In a previous study, we found that OTM increases in cholestatic rats,11
thus the aim of the present study was to examine the rate of OTM in subsequent cirrhosis, as well as the amount of bone (using densitometry and osteoclast counts) and root resorption in cholestatic and cirrhotic rats.
| Methods and materials |
|---|
|
|
|---|
The rats were randomly divided up into five experimental groups. Each group consisted of eight rats which were randomly housed in two cages (four rats in each cage). The sample size of eight animals/group was based on the numbers used in previous studies.11
,12
Experimental groups were: (1) control group, (2) and (3) sham-operated groups that underwent sham operation without bile duct ligation, (4) cholestatic group, and (5) cirrhotic group. An orthodontic appliance was placed 7 days after the surgery in groups (1), (2) and (4) and 28 days after surgery in groups (3) and (5).
Surgery
Midline laparotomy was performed under general anaesthesia induced by intraperitoneal (IP) injection of ketamine HCl (50 mg/kg) and promazine HCl (10 mg/kg).10
In bile duct ligated animals (groups (4) and (5)), the bile duct was isolated, doubly ligated and resected between the ligatures.12
In the sham groups, the bile duct was identified, manipulated and left in situ.13
–15
Bile duct ligation is a standard method that is extensively used as an animal model of cholestasis and biliary cirrhosis.12
One day after surgery, bile duct-ligated rats showed signs of overt cholestasis such as jaundice, dark urine and steatorrhoea. These manifestations were not seen in any of the sham-operated animals. In the biliary cirrhotic rats (28 days after bile duct ligation), there were manifestations of cholestasis and also increased body weight gain, ascites (as evidenced by visible pools of fluid in the lateral abdomen) and postmortem histological examination.14
,15
Orthodontic treatment and OTM measurements
All five study groups received orthodontic treatment. Each rat was anesthetized with an IP injection of ketamine HCl (50 mg/kg) and promazine HCl (10 mg/kg). The orthodontic appliance used was a replication of the appliance presented by King and Fischlschweiger.16
An orthodontic force of 60 g was applied with a 5 mm long nickel titanium closed-coil spring (NiTi, 3M Unitek, Monrovia, CA, US Hitek, 0.006 x 0.022-inch) running between the right upper first molar and incisor. The spring was connected to the first molar and central incisor via ligature wires (Dentaurum Steel Ligature Wire 0.010-inch, Dentaurum Group, Ispringen, Germany). Due to a lack of undercuts in the incisor area, a cervical groove was prepared on the tooth where the ligature wire could be seated in and secured by composite resin (Self-cure Degufill, Degussa AG, Frankfurt Germany) on both incisors. Each spring was activated once to produce 60 g of force which was measured by spring gauge device.
Two weeks after appliance insertion, the animals were killed using cervical dislocation. Orthodontic tooth movements (OTM) were then measured using a filler gauge (Mitutoyo Corp., Kawasaki-Shi, Japan) directly in the mouth to measure the distance between the first and second right molars. This distance was initially zero in the samples.
Bone densitometry
Digital lateral skull images at the end of the experiment were obtained. The investigators were unaware of which experimental group each rat belonged to. Pixel intensity analysis is a measure of the blackness or whiteness in a digital image. Pixel intensity analysis could be a simple and useful method to measure mandibular bone mass, and it has been suggested as a method to detect the presence of osteoporosis. The square of 50 x 50 pixels was located immediately above the maxillary molars.17
,18
Histologic analysis
Histomorphometric analysis of root resorption on the mesial and distal surfaces of the mesial root of the first molar was performed. All micrographs were taken under x 40, and all were stained by haematoxylin and eosin. The investigators were unaware of which experimental groups the rats belonged to. The estimation of root resorption for the purpose of this experiment was defined as any clear interruption of the cemental or dentinal surface. The following measurements (which served as root resorption parameters) were recorded and evaluated statistically for differences between groups at a significance level of P<0.05.
Statistical analysis
As all groups of data proved to be normally distributed ANOVA (analysis of variance) followed by Tukeys post hoc test was used to detect and locate statistically significant differences. P<0.05 was considered statistically significant.
| Results |
|---|
|
|
|---|
|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Previous studies have shown that different factors might influence the rate of OTM via various biomediators. It has been reported that intracellular second messengers (Ca2+, cGMP and cAMP) play an important role in the differentiation of osteoclasts from monocytes in bone resorption during mechanical orthodontic force application.20
,21
Orthodontic mechanical stress may induce localized cells to synthesize prostaglandins, which stimulate osteoclastic bone resorption.22
,23
In BDL rats, alkaline phosphatase (ALP) elevates and is obviously suppressed by prior administration of indomethacin. Prostaglandin is a possible ALP inducer in BDL rats, probably working by elevating the cAMP level.24
It has been shown that, in cirrhosis, mean trabecular bone volume is significantly reduced and mean osteoclastic per surface length and total bone resorption surfaces are considerably increased.8
,9
,11
The histological data in the present study revealed that more osteoclasts and bone resorption were seen in the cholestatic and cirrhotic groups compared to control and sham groups. However, it was not significant. This discrepancy in our results might be due the small number of animals in each experimental group in our study which warrants further studies with larger sample sizes and based on appropriate sample size calculations.
Parathyroid hormone (PTH) increases serum calcium by direct and indirect vitamin D-mediated effects. Vitamin D3 is important in maintaining the integrity of bone collagen.25
It has also been shown that the rate of synthesis of soft tissue mature collagen decreases with calcium and vitamin D3 deficiency. Therefore, a decreased synthesis of vitamin D may partly be responsible for the increase of OTM. It is established that vitamin 25(OH)D3 decreases in bile duct ligated cirrhotic rats.4
,5
Lower levels of 25(OH)D3 in the BDL rats could have resulted from vitamin D malabsorption caused by intraluminal bile salt deficiency,26
inhibition of hepatic vitamin D25-hydroxylase by bile acid accumulation in BDL rats,27
increased urinary clearance of vitamin D,28
and lower levels of albumin and vitamin D binding protein in the BDL rats as previously reported.29
The elevation of total opioid activity in BDL rats30
,31
also can contribute to changes of bone metabolism. Human osteoblast-like cells, MG-63, present immunohistochemical reactivity of mu, delta and kappa; three main specific cell surface opioid receptors.32
,33
High concentrations of morphine inhibit the 1,25(OH)2 D3-induced osteocalcin secretion.34
The role of the opioid system on OTM in BDL rats is established.11
Taken together and according to the results of the present study, more detailed studies are clearly needed for demonstrating the exact mechanisms by which the OTM is increased in biliary cirrhotic condition.
Previous studies have provided evidence in favour of nitric oxide (NO) overproduction in various tissues and systems in animal models of cholestasis.35
–37
It is suggested that orthodontic forces may elevate NO production from periodontal ligament fibroblasts, which then activates guanylyl cyclase in periodontal ligament fibroblasts, leading to an increased level of cGMP.38
,39
NO administration also increases the biosynthesis of prostaglandins by cGMP.40
cGMP in cell cytoplasm raises lysosome membrane permeability, leading to exocytosis of lysosome content resulting in resorption of organic and mineral element of bone. NO may diffuse to the alveolar bone and influence the function of osteoclastic differentiation.41
Thus NO plays a role in bone resorption and formation and facilitates these phenomena during force application. It has been reported that NO increases OTM in rats.42
–44
Other factors may be implicated in generation of increased OTM in cirrhosis and cholestasis. Reduced formation of IGF-1, an important bone growth factor,45
decreased serum osteocalcin level,46
accumulation of toxic substances that impair the function of the osteoblasts,47
were found in cirrhotic rats. These factors may be partly responsible for the increase of OTM. Thus the present study shows that OTM increases in BDL rats and bone density decreases in cholestatic and cirrhotic groups. This suggests that osteopenia and impairment of bone remodelling in BDL subjects might lead to an increased rate of tooth movement and decreased bone density.
| Conclusion |
|---|
|
|
|---|
| Contributors |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
2 Hodgson SF, Dickson ER, Wahner HW, Johnson KA, Mann KG, Riggs BL. Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med 1985; 103: 855–60.[Medline]
3 Compston JE, Thompson RP. Intestinal absorption of 25-hydroxyvitamin D and osteomalacia in primary biliary cirrhosis. Lancet 1977; 1: 721–24.[Medline]
4 Long RG, Meinhard E, Skinner RK, Varghese Z, Wills MR, Sherlock S. Clinical, biochemical, and histological studies of osteomalacia, osteoporosis and parathyroid function in chronic liver disease. Gut 1978; 19: 85–90.
5 Reed JS, Meredith SC, Nemchausky BA, Rosenberg IH, Boyer JL. Bone disease in primary biliary cirrhosis: reversal of osteomalacia with oral 25-hydroxyvitamin D. Gastroenterology 1980; 78: 512–17.[Medline]
6 Stellon AJ, Webb A, Compston J, Williams R. Lack of osteomalacia in chronic cholestatic liver disease. Bone 1986; 7: 181–85.[Medline]
7 Diamond TH, Stiel D, Lunzer M, McDowall D, Eckstein RP, Posen S. Hepatic osteodystrophy. Static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease. Gastroenterology 1989; 96: 213–21.[Medline]
8 Cuthbert JA, Pak CY, Zerwekh JE, Glass KD, Combes B. Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia. Hepatology 1984; 4: 1–8.[Medline]
9 Shih MS, Anderson C. Does hepatic osteodystrophy differ from peri- and post menopausal osteoporosis? A histomorphometric study. Calcif Tissue Int 1987; 41: 187–91.[CrossRef][Medline]
10 Tilg H, Day CP. Management strategies in alcoholic liver disease. Nat Clin Pract Gastroenterol Hepatol. 2007; 4: 24–34.[CrossRef][Medline]
11 Nilforoushan D, Shirazi M, Dehpour AR. The role of opioid systems on orthodontic tooth movement in cholestatic rats. Angle Orthod 2002; 72: 476–80.[Medline]
12 Vaziri H, Naserhojjati-Roodsari R, Tahsili-Fahadan P, et al. Effect of simvastatin administration on periodontitis-associated bone loss in ovariectomized rats. J Periodontol 2007; 78(8):1561–67.[CrossRef][Medline]
13 Jancsó G, Kiraly E, Jancsó-Gabór A. Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones. Nature 1977; 270: 741–43.[CrossRef][Medline]
14 Ghasemi M, Sadeghipour H, Shafaroodi H, et al. Role of the nitric oxide pathway and the endocannabinoid system in neurogenic relaxation of corpus cavernosum from biliary cirrhotic rats. Br J Pharmacol 2007; 151: 591–601.[CrossRef][Medline]
15 Corbin IR, Buist R, Peeling J, Zhang M, Uhanova J, Minuk GY. Hepatic 31P MRS in rat models of chronic liver disease: assessing the extent and progression of disease. Gut 2003; 52: 1046–53.
16 King GJ, Fischlschweiger W. The effect of force magnitude on extractable bone resorptive activity and cemental cratering in orthodontic tooth movement. J Dent Res 1982; 61: 775–79.
17 Law AN, Bollen AM, Chen SK. Detecting osteoporosis using dental radiographs: a comparision of four methods. J Am Dent Assoc 1996; 127: 1734–42.
18 Tosoni GM, Lurie AG, Cowan AE, Burleson JA. Pixel intensity and fractal analyses: detecting osteoporosis in perimenopausal and postmenopausal women by using digital panoramic images. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102: 235–41.[CrossRef][Medline]
19 Boekenoogen DI, Sinha PK, Nanda RS, Ghosh J, Currier GF, Howes RI. The effects of exogenous prostaglandin E2 on root resorption in rats. Am J Orthod Dentofacial Orthop 1996; 109: 277–86.[CrossRef][Medline]
20 Davidovitch Z, Shanfeld JL. Cyclic AMP levels in alveolar bone of orthodontically-treated cats. Arch Oral Biol 1975; 20: 567–74.[CrossRef][Medline]
21 King GJ, Keeling SD, McCoy EA, Ward TH. Measuring dental drift and orthodontic tooth movement in response to various initial forces in adult rats. Am J Orthod Dentofacial Orthop 1991; 99: 456–65.[Medline]
22 Yamasaki K, Shibata Y, Imai S, Tani Y, Shibasak: Y, Fukuhara T. Clinical application of prostaglandin E1 (PGE1) up on orthodontic tooth movement. Am J Orthod 1984; 85: 508–18.[CrossRef][Medline]
23 Yamasaki K, Miura F, Suda T. Prostaglandin as a mediator of bone resorption induced by experimental tooth movement in rats. J Dent Res 1980; 54: 1635–42.
24 Komoda T, Koyama I, Nagata A, Sakagishi Y, Kurata M, Kumegawa M. A possible mechanism of induction and translocation into blood stream of rat alkaline phosphatase activity by bile duct ligation. Arch Biochem Biophys 1986; 251: 323–35.[CrossRef][Medline]
25 Russell JE, Avioli LV. Effect of experimental chronic renal insufficiency on bone mineral and collagen maturation. J Clin Invest 1972; 51: 3072–78.[CrossRef][Medline]
26 Plourde V, Gascon-Barré M, Williams B, Huet PM. Severe cholestasis leads to vitamin D depletion without perturbing its C-25 hydroxylation in the dog. Hepatology 1988; 8: 1577–85.[CrossRef][Medline]
27 Bolt MJ, Sitrin MD, Favus MJ, Rosenberg IH. Hepatic vitamin D25-hydroxylase: inhibition by bile duct ligation or bile salts. Hepatology 1981; 1: 436–40.[CrossRef][Medline]
28 Mawer EB, Klass HJ, Warnes TW, Berry JL. Metabolism of vitamin D in patients with primary biliary cirrhosis and alcoholic liver disease. Clin Sci (Lond) 1985; 69: 561–70.[Medline]
29 Diamond T, Stiel D, Mason R, et al. Serum vitamin D metabolites are not responsible for low turnover osteoporosis in chronic liver disease. J Clin Endocrinol Metab 1989; 69: 1234–39.
30 Swain MG, Rothman RB, Xu H, Vergalla J, Bergasa NV, Jones EA. Endogenous opioid accumulate in plasma in a rat model of acute cholestasis. Gastroenterology 1992; 103: 630–35.[Medline]
31 Swain MG, MacArthur L, Vergalla J, Jones EA. Adrenal secretion of BAM-22P, a potent opioid peptide, is enhanced in rats with acute cholestasis. Am J Physiol 1994; 266: G201–5.[Medline]
32 Simon EJ. Multiple opioid receptors. In: Almedia OF, Shippenberg TS (Eds). Neurobiology of Opioids. Berlin: Springer Verlag, 1991, 75–88.
33 Brownstein MJ. A brief history of opiates, opioid peptides, and opioid receptors. Proc Natl Acad Sci USA 1993; 90: 5391–93.
34 Pérez-Castrillón JL, Olmos JM, Gómez JJ, et al. Expression of opioid receptors in osteoblast-like MG-63 cells, and effects of different opioid agonists on alkaline phosphatase and osteocalcin secretion by these cells. Neuroendocrinology 2000; 72: 187–94.[CrossRef][Medline]
35 Nahavandi A, Dehpour AR, Mani AR, Homayounfar H. Abdoli A. N(G)-nitro-L-arginine methylester is protective against ethanol-induced gastric damage in cholestatic rats. Eur J Pharmacol 1999; 370: 283–86.[CrossRef][Medline]
36 Nahavandi A, Dehpour AR, Mani AR, Homayounfar H, Abdoli A, Abdolhoseini MR. The role of nitric oxide in bradycardia of rats with obstructive cholestasis. Eur J Pharmacol 2001; 411: 135–41.[CrossRef][Medline]
37 Nahavandi A, Mani AR, Homayounfar H, Akbari MR, Dehpour AR. The role of the interaction between endogenous opioids and nitric oxide in the pathophysiology of ethanol-induced gastric damage in cholestatic rats. Fundam Clin Pharmacol 2001; 15: 181–87.[CrossRef][Medline]
38 Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109–42.[Medline]
39 Bredt DS, Synder SH. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 1994; 63: 175–95.[CrossRef][Medline]
40 Sautebin L, Ialenti A, Ianaro A, Di Rosa M. Modulation by nitric oxide of prostaglandin biosynthesis in the rat. Br J Pharmacol 1995; 114: 323–28.[Medline]
41 Hikiji H, Shin WS, Oida S, Takato T, Koizumi T, Toyo-oka T. Direct action of nitric oxide on osteoblastic differentiation. FEBS Lett 1997; 410: 238–42.[CrossRef][Medline]
42 Shirazi M, Nilforoushan D, Alghasi H, Dehpour AR. The role of nitric oxide in orthodontic tooth movement in rats. Angle Orthod 2002; 72: 211–15.[Medline]
43 Hayashi K, Igarashi K, Miyoshi K, Shinoda H, Mitani H. Involvement of nitric oxide in orthodontic tooth movement in rats. Am J Orthod Dentofacial Orthop 2002; 122: 306–9.[CrossRef][Medline]
44 Akin E. Gurton U, Olmez H. Effects of nitric oxide in orthodontic tooth movement in rats. Am J Orthod Dentofacial Orthop 2004; 126: 608–14.[CrossRef][Medline]
45 Hattori N, Kurahachi H, Ikekubo K, et al. Serum growth hormone-binding protein, insulin-like growth factor-I and growth hormone in patients with liver cirrhosis. Metabolism 1992; 41: 377–81.[CrossRef][Medline]
46 Ackerman Z, Weinreb M, Amir G, Pollak RD. Bone mineral metabolism and histomorphometry in rats with cholestatic liver disease. Liver 2002; 22: 166–72.[CrossRef][Medline]
47 Janes CH, Dickson ER, Okazaki R, Bonde S, McDonagh AF, Riggs BL. Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest 1995; 95: 2581–86.[Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |